GlassScriptPhysician profile
Travis Christopher Allemang
NPI 1841586120
$1,951.34
in general payments reported to CMS, 2019-2025
23 companies · $631 in 2025
The $631 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2023: $721 · 2024: $434 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,785.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $266.53 | 2023-2025 | Titan |
| Teleflex LLC | $245.43 | 2024-2025 | Barrigel, Urolift |
| Intuitive Surgical, INC. | $239.95 | 2023 | |
| Astellas Pharma US INC | $184.33 | 2019-2025 | Xtandi |
| Boston Scientific Corporation | $150.20 | 2024-2025 | Greenlight Xps, Lithovue, Rezum Generator |
| Karl Storz Endoscopy-America | $137.46 | 2023 | Flex-X |
| Endo USA, INC. | $114.13 | 2024-2025 | Xiaflex |
| Pfizer INC. | $78.57 | 2023-2024 | |
| Cook Medical LLC | $62.49 | 2019 | |
| Innovation Technologies INC | $61.05 | 2024-2025 | Irrisept |
| Tolmar, INC. | $58.75 | 2025 | Eligard, Jatenzo |
| Ferring Pharmaceuticals INC. | $57.49 | 2024-2025 | Adstiladrin |
| Becton, Dickinson and Company | $46.59 | 2025 | Bard Urinary Drainage Bag |
| Endo Pharmaceuticals INC. | $43.51 | 2023-2024 | Xiaflex |
| Sumitomo Pharma America, INC. | $31.26 | 2023-2024 | Orgovyx, Gemtesa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $29.01 | 2024 | Jnw Urtrac |
| Urogen Pharma, INC. | $27.71 | 2025 | |
| Abbvie INC. | $23.14 | 2023 | Lupron Depot |
| Axonics, INC. | $21.10 | 2023 | Axonics |
| Immunitybio, INC. | $20.28 | 2025 | |
| Angiodynamics, INC. | $19.62 | 2025 | Nanoknife |
| Calyxo, INC. | $19.31 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $13.43 | 2024 | Aquabeam System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Allemang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.